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Introduction
Biocides (antiseptics, disinfectants and pre-
servatives) are usually broad spectrum chemi-
cal agents that inactivate micro-organisms
(Russell, 2003; McDonnell and Russell, 1999)
and their effects are highly concentration
dependent (Russell and McDonnell, 2000). The
history of biocide and other antimicrobial
agent usage in various forms and applicati-
ons dates back centuries (Russell, 2002). Micro-
organisms, although vital for our health and
environment, may also pose a risk to human
health and can cause serious problems and
economic loss in various industries. Biocides
are thus used to disinfect, to eliminate unde-
sired organisms, preserve and conserve vario-
us products (Rasmussen et al., 1999). On the
other hand, the desired properties of biocides
include minimal toxicity and eco-toxicity, yet
they need to have spectrum of activity and
stability adapted to the application in questi-
on (Paulus, 1996).
Biocides are used in a variety of different
products and applications, where the conse-
quences of possible microbial contamination
and spoilage range from being life-threate-
ning, e.g. in pharmaceuticals (Zani et al., 1997)
and in food (Raczek, 2005) to deterioration of
product quality and product recall costs with
negative implications to consumer choice e.g.
cosmetics, skin care products and toiletries
(Scholtyssek, 2005). Biocides are also used in
the prevention of microbial spoilage of fuel
and oilfield operations (Robbins and Levy, 2005;
McIlwaine, 2005). Biocides are added to the
formulations of polymer dispersions, mineral
dispersions and paints (Gillatt, 2005; Schwar-
zentruber and Gane, 2005; Lindner, 2005). Bio-
cides are also needed for the protection and
preservation of plastics, textiles and leather
(Dylingowsky and Hamel, 2005; Wypkema,
2005; Hauber, 2005). In the pulp and paper
industry biocides play an important role in
different processes where they are crucial espe-
cially in the prevention and controlling of bio-
film formation (Corbel, 2005). An important
biocide application is microbiological quality
control in cooling water systems and in recrea-
tional water applications, such as swimming
pools, spas and water amusement parks
(Ludensky, 2005; Unhoch and Vore, 2005). In
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addition, biocides are used in the protection
of industrial wood and water-mixed coolants
(Williams, 2005; Siegert, 2005).
Accordingly, the usage of biocides covers a
vast industrial area and applications thereof.
In 2004 the world biocide demand was 5,300
million dollars from which 2,620 million dol-
lars (49%) was used for preservatives, 1,685
million dollars (32%) for water treatment and
995 million dollars (19%) for disinfectants or
for industrial processes. By 2009 the world bio-
cide demand is estimated to grow to 6,880 mil-
lion dollars (5.4% annual growth from 2004)
and by 2014 to 9,050 million dollars (5.6% annu-
al growth from 2009) (Freedonia, 2005). Cur-
rently, the biocides industry as a whole is
governed by end-industry growth, technolo-
gical developments, regulatory changes and
the growing use of biocides as an aid to impro-
ve hygiene (Anon., 2007; Anon., 2008a). On the
other hand, the industry and R&D of new bio-
cides faces challenges because of the changing
industrial and regulatory environment (Bruns
et al., 2005). The registration costs of the EU-
wide Biocidal Products Directive including all
toxicological tests have been estimated at 3-4
million euros (Bruns et al., 2005), which will
not ease the existing stagnation of biocidal
product development. Moreover, only limited
efforts are being invested in the R&D of new
Active Ingredients and many of the compa-
nies manufacturing biocides have focused on
making new biocide combinations from exis-
ting Active Ingredients (AI). The term Active
Ingredient (AI) is an even more precise term
when referring to the actual compound which
is responsible for the functional properties of
the biocide. On the other hand, biocidal pro-
ducts may also be formulations of many Acti-
ve Ingredients (Paulus, 2005; Bruns et al., 2005).
In addition, the EU Biocidal Products Directi-
ve (BPD) 98/8/EC uses the term Active Sub-
stance when addressing Active Ingredients
(Anon., 1998).
The BPD 98/8/EC addresses the placing of
biocidal products on the EU market. The aim
of the Directive is to enforce an authorization
procedure based on a risk assessment for pro-
ducts containing biocidal active substance
before placing the products on the market. The
objective of BPD is also to remove barriers of
trade between Member States and create a
harmonised high degree of protection for
people and the environment (Rasmussen and
MacLellan, 2001). The BPD applies to 23 diffe-
rent product types listed in Annex V of the
Directive but excludes some product types
covered by other Community legislation, e.g.
cosmetics (Matthews, 2002; Anon., 1998). The
BPD entered into force May 1998 and 24
months was given to Member States to imple-
ment the directive. A 10-year period following
the implementation deadline within the Mem-
ber States was given to evaluate all active sub-
stances used in all products. After this period,
active substances not found from the directi-
ve’s Annexes I, IA or IB must be withdrawn
from the market for use as biocides as must
also the products in which they are used (Ras-
mussen et al., 1999). The EC Commission Regu-
lation of BPD has listed some 1,000 active sub-
stances from which only over 300 active sub-
stances and product types were included in
the original review programme (Anon., 2003).
The BPD regulation requires extensive testing
of all biocidal products before they are regis-
tered for sale and the registration is required
for both new and old biocides (Bruns et al.,
2005).
Accordingly, emerging EU regulations (BPD,
REACH and others) strive to increase the safety
and the eco-efficiency of chemical products
and production processes. However, it may be
argued that such changes will create voids in
the availability of current biocides, which may
become out-phased. It therefore follows that
the chemical industry is in need of new AI
development in order to comply with new
regulations and demands for increased envi-
ronmental stewardship. Consequently, we have
studied the economic feasibility of new AI
development and the need for such develop-
ment from an industry viewpoint. In order to
address these questions, a profitability eva-
luation for a new AI was performed based on
the net present value (NPV) and discounted
payback period (DPP). In addition, data was
collected by interviews in order to obtain an
overview from different industries on needs
and views with reference to biocides and new
product development thereof.
Methods
Profitability evaluation using a sensitivity
analysis
The basic measure of profitability is the net
present value (NPV) of a new AI development.
A development project should be carried out
if the discounted net cash flows during the
AI’s life cycle exceed the R&D investment, i.e.
NPV is greater than zero. Our data is based on
general estimates of development costs (Käh-
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könen and Nordström, 2009) and as well as on
biocide demand (Freedonia 2005) but inclu-
des no information on specific competition
and manufacturing operations. Therefore, NPV
is estimated according to Equation 1.
(1)
I0 = R&D investment
T = economic life of the AI to be developed
Dt = demand of biocides in Europe in year T
s = market share of the AI to be developed
c = net cash flow as a percentage of annu-
al sales
r = discount rate
It should be noted that the net cash flow
percentage (c) contains implicit assumption
concerning operating profit margin, cash cycle
of the operations and tax rate. Likewise, the
market share depends on future pricing deci-
sions concerning not only the AI but its rivals
or substitutes.
Therefore, the purpose of the economic ana-
lysis is to explore the boundaries of economic
feasibility. The approach is that of a sensitivi-
ty analysis or break-even analysis, to be more
specific (Brealey and Myers, 2003). In a break-
even analysis, the analyst seeks for boundary
values that make the projects NPV equal zero.
In order to facilitate the comparison of scena-
rios, we also use discounted payback period
(DPP) as an indicator. The discounted payback
period points to the minimum economic life
(T) that makes NPV positive.
Industry Interviews
Interview data was collected in 2008 and
selected Finnish companies were chosen to
represent various industries utilizing bioci-
des. The interviewed Finnish companies manu-
factured 1) adhesives and related products; 2)
pharmaceuticals; 3) cosmetics and skin care
products; 4) polymer dispersions; and 5) bio-
cides for the use of mainly pulp and paper
industry. In addition, four companies opera-
ting in the paint industry were also included
in the study but the data was collected by using
a questionnaire form. The oral interviews were
conducted in a semi-structured manner (a focu-
sed interview) (Hirsjärvi and Hurme, 1993; Tiit-
tula and Ruusuvuori, 2005). All the interviews
were recorded and documented in writing
afterwards. Although the interviews dealt with
three different themes (Table 1, see appendix
1), only the answers concerning the focus area
of the present study were analyzed.
In addition to the interview data collected
from the industries utilizing biocides, a repre-
sentative from the Finnish Allergy and Asth-
ma Federation was interviewed (Table 2, see
appendix 2). The interview on preservative
allergies was also conducted in a semi structu-
red manner (a focused interview) (Hirsjärvi
and Hurme, 1993; Tiittula and Ruusuvuori,
2005) and the interview was recorded and
documented in writing afterwards.
Results
Profitability of a new biocide
The basic parameters of the NPV model are
R&D investment, demand and discount rate.
After setting values for these parameters, we
have sought the break-even values for market
share and net cash flow percentage. Based on
a previous study, the R&D investment is esti-
mated to be € 3.13 million (Table 3).
The demand estimates are only for Europe
and are based on the summed value of the
demand in Western and Eastern Europe in
2009 (Table 4). According to the data in Table
4 the biocide demand in Europe as a whole in
2009 is 2,060 million dollars. Converted to
euros (€ = US$ 1.3705 in 2007; Anon., 2008b)
the demand for biocides in 2009 in Europe is
1,503 million euros1. The expected growth for
the biocide demand of the world is estimated
as 5.6% annually from 2009 until 2014. This
growth estimate of the world biocide demand
is used in the calculations although covering
only Europe. The new AI is assumed to be on
the market at the beginning of the year 2009
(t=1) and on the market for at least until 2030
(T=22). The estimated market life is in
alignment with the long life cycles of the many
currently used biocides. As there is no growth
estimate beyond 2014 provided by Freedonia
(2005) or any other public source, the calcula-
tions are based on an assumption of an annu-
al growth percentage of 3.0 from 2015 until
2020 and 1.0 from 2021 to 2030.
The diffusion time of a new product into
Feasibility of Active Ingredient (AI) Development for New Biocides in the EU
1) Using the average exchange rate of 2004, i.e. the year the demand forecast was made, the demand in Europe would be €1,661 million.
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2) This growth rate leads to the same demand in 2030 as the original estimate.
the market is not taken into account and the-
refore the market share is assumed to be gai-
ned immediately. The discount rate is assu-
med to be 10% throughout the life cycle. Dis-
count rate and annual demand in euro repre-
sent nominal values.
Since the main purpose is to justify furt-
her investigations in AI development, we have
searched for modest target levels of market
share and net cash flow percentage. If one
accepts a discounted payback period of 22 years
and net cash flow percentage of 5%, the requi-
red market share is 0.36%. A market share of
0.18% would be sufficient if net cash flow per-
centage were 10%. The form of Equation 1
shows that the relationship between these
two variables is linear ceteris paribus. If we
assume a discount rate of 15%, the respective
figures are (5%, 0.51%) and (10%, 0.26%). If we
assume a more moderate market growth,
namely a constant growth rate of 2.65%2, a dis-
count rate of 10% and a net cash flow percen-
tage of 5% would require a market share of
0.39%. Table 5 illustrates another scenario with
the initial assumptions. Under more favoura-
ble conditions, NPV can be much greater than
zero and the discounted payback period less
than 10 years. As a conclusion, it can be stated
that in order to become profitable in the bio-
cide market in Europe, the minimum targeted
market share should be approximately 0.4%
for a new AI. This is consistent with a net sales
target of 6 million euros for the first year.
Views of the industry and need for new bio-
cides
The interviews of the present study indi-
cated that industry representatives are con-
cerned about the changes in legislation and
consequent effects on available biocides. The
interviewees operating in the business-to-
business field highlighted that warning labels
in products were not desired. REACH was
thought to affect the availability and warning
labelling or to increase the prices of the used
raw materials. REACH was also seen as
affecting companies via the required pre-regis-
tration demands. Only one interviewee esti-
mated that the BPD would increase prices of
biocides. This same interviewee also believed
that no new AIs would be able to enter the bio-
cide market due to the high costs of BPD for
new AIs. In addition, eco-labels were also men-
tioned as affecting the use of biocides.
Depending on the industry, preservatives
such as formaldehyde (and formaldehyde relea-
sing compounds) and parabens were named
as controversial biocides. Formaldehyde was
avoided or not used at all due to its toxicity,
but also due to changed customer demands,
the EU Water Framework Directive and due to
environmental labels such as the Blue Angel
(Der Blaue Engel). Representatives who men-
tioned these were from the adhesives and rela-
ted products company and the polymer dis-
persions company. The industry representati-
ves of the pharmaceuticals and cosmetics field
stated that there is a trend to discontinue the
use of parabens due to possible allergies and
negative media hype. These examples indica-
te problems with currently used biocides and
the lack of alternative biocides.
Properties needed for new biocides
Differing views were presented as to the
kinds of properties a new biocide should ide-
ally have. Only one interviewee stated that a
new biocide should comply with certain stan-
dards so that use of such a biocide would not
lead to demands for warning labels. More-
over, the biocide should be effective so that it
could be used only in small amounts. On the
contrary, however, another interviewee stated
that it would be useful if a new biocide could
be used in large amounts, but without war-
ning labels. In general, interviewees were of
the opinion that a new biocide should be highly
effective, broad-spectrum and safe to use with
no sensitization problems. In addition, the
interviewees from the paint industry all agreed
that there is a clear need for new dry film pre-
servatives.
There also appears to be need for biocides
that would function with a completely diffe-
rent mechanism compared to the biocides in
use currently. Such a new biocide could be e.g.
some natural raw material that would have
biocidal attributes. It was also mentioned that
a new biocide should also be suitable for many
different kinds of products and have a good
solubility. The company manufacturing bio-
cides listed cost-effectiveness as the most
important attribute in addition to the biocide
being safe and rapidly degradable to harmless
end-products.
A highly important issue that also arose in
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the interviews was a need for new biocide effi-
cacy testing methods. Interviews of the paint
industry indicated that the most important
area for basic research on biocides is determi-
nation of biocide efficacy. In addition, the repre-
sentative of the company manufacturing adhe-
sives and related products stated that micro-
biological knowledge and business related to
biocide efficacy and product preservability is
still limited. More efficient and specific
methods for biocide efficacy testing are thus
called for. They are also crucial for the deve-
lopment of new biocides as giving a basis for
the development process of a new AI.
In addition, also the non-biocidal solutions
and alternatives to chemical biocides were dis-
cussed in the interviews. Although there was
no direct question on non-biocidal means for
microbial control, many of the interviewees
mentioned non-biocidal alternatives during
the interviews and the importance of phrases
such as ‘preservative-free’ in advertising. The
representative from the cosmetics field empha-
sized that there is an ongoing trend towards
reducing the use of preservatives. This inter-
viewee also stated that if the product can be
marketed as ‘preservative-free’, it clearly adds
value to the product. The representative from
the pharmaceuticals field also mentioned this
same trend and the possibility of using e.g.
disposable packages or preserving packaging
technology instead. This interviewee also men-
tioned that there is a trend towards disposa-
ble packages.
The Finnish Allergy and Asthma Federati-
on interview revealed aspects of the sensiti-
zing potential of many preservatives. The inter-
viewee emphasized that even though the num-
ber of some allergies has increased during
recent years, this should not be interpreted as
a proliferation of allergies in general. Rather,
the increase is due to increased knowledge on
Start-up costs / AI Average cost (M€)
R & D 0.240
EHS risk evaluation tests according to regulations and dossier composition 2.650
Registration fee in the EU 0.120
Other e.g. manufacturing costs 0.120
Total costs 3.130
Table 3 The estimated start-up costs for the development of a new AI
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Biocide demand (M US$) Annual Growth %
Item 1999 2004 2009 2014 04/99 09/04 14/09
World GDP (bil 2000 $) 43,000 51,050 62,150 75,900 3.5 4.0 4.1
$biocide/mil $ GDP 98 104 111 119 -- -- --
World biocide demand 4,225 5,300 6,880 9,050 4.6 5.4 5.6
North America: 1,925 2,300 2,890 3,620 3.6 4.7 4.6
United States 1,735 2,060 2,580 3,220 3.5 4.6 4.5
Canada & Mexico 190 240 310 400 4.8 5.3 5.2
Asia/Pacific: 820 1,145 1,650 2,465 6.9 7.6 8.4
China 138 286 553 1,048 15.7 14.1 13.6
Japan 416 473 544 627 2.6 2.8 2.9
Other Asia/Pacific 266 386 553 790 7.7 7.5 7.4
Other Regions: 290 425 600 840 7.9 7.1 7.0
Latin America 104 127 169 222 4.1 5.9 5.6
Eastern Europe 127 215 320 472 11.1 8.3 8.1
Africa/Mideast 59 83 111 146 7.1 6.0 5.6
Western Europe 1,190 1,430 1,740 2,125 3.7 4.0 4.1
Table 4 World biocide demand (in millions of dollars) from 1999 to 2014 and percentage annual growth
Source: Kähkönen and Nordström, 2009
Source: Freedonia, 2005
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and diagnostics of allergies. Even though aller-
gies have not increased, the interviewee men-
tioned that the so called ‘sensitivity markets’
have grown during the last few years especi-
ally in the cosmetics field. In new AI develop-
ment the sensitizing aspect is therefore a cru-
cial aspect to be taken into account as many
preserved products are used on skin on a daily
basis. On the other hand, industrial preserving
methods should be environmentally friendly
and should not be bio-accumulative.
Limitations of the study
The interviews conducted in this study
represent a qualitative research method. A
potential challenge in achieving validity in
qualitative research is researcher bias, arising
out of selective collection and recording of
data, or from interpretation based on perso-
nal perspectives (Johnson, 1997). This also
applies to the present study as the intervie-
wed sample was small and consisted of indus-
try representatives who were not selected
through random sampling. However, although
the number of interviewees is rather limited,
it is to be noted that the interviewees repre-
sented companies with a vast range of bioci-
de application needs. Moreover, at this point
the aim of our study was only to shed some
preliminary insight into the needs and views
of the industry and whether there is any indi-
cation that such views take into account the
cost of new biocide/AI development.
In this study, the calculations were perfor-
med in order to give a rough estimate rather
than precise figures. This was due to the limi-
ted initial information and consequently the
many assumptions that had to be made.
Moreover, the conversion of the initial nume-
ric data from dollars to euros clearly is depen-
dent on the used exchange rate and therefo-
re affects the value of the turnover and cash
flow estimates. The calculations were perfor-
med based on the biocide market size estima-
tes published in 2005 as this was the newest
available information. However, the current
financial situation clearly has an influence
and more recent market growth assumptions
would presumably be different and more
moderate. The financial situation was, howe-
ver, taken into consideration by making the
longer term growth assumptions rather on the
low side in order not to overestimate the mar-
ket size. In addition, the calculations were per-
formed using a sensitivity analysis where
various different estimates of the cash flows
were calculated.
The calculations of this study focused only
on the assessment of the net present value
and the discounted payback period based on
the basic initial costs which composed main-
ly of the registration fee, EHS risk evaluation
costs and moderate R&D costs. However, deve-
loping an AI with the attributes specifically
wished for by the industry representatives
might increase the estimated R&D costs even
heavily. But as the estimation of these speci-
fic R&D costs would be highly inaccurate and
difficult, the calculations were carried out
using a very moderate estimate of the start-
up costs. Clearly, these calculations can be
made more accurate when more information
on the development and other costs is availa-
ble. In addition, the calculations in this study
do not take into account those R&D costs and
development processes which do not lead to
a desired outcome. In further studies when
more initial information is available, different
and more complex calculation models can be
used for profitability evaluation.
Discussion
While the changing industrial environment
of the biocide market and the high registrati-
on costs of the BPD are not generally seen as
an incentive for developing new AIs, the indus-
try needs should be seen as one instead. The
conducted interviews echo the opinions of
industries and speak on behalf of new AI deve-
lopment. In addition, the limited number of
available biocides can be seen as a problem,
especially if the number of the AIs in use cur-
rently decreases due to the BPD as has been
speculated (Bruns et al., 2005; Chapman, 2003).
The EC Commission Regulation of BPD has lis-
ted some 1000 active substances from which
only over 300 active substances and product
types were included in the review program-
me (Anon., 2003).
The data of the present study does not sup-
port the general opinion that development of
new AIs would be economically unfeasible.
Rather, it is evident that the payback time for
new developments will increase, but as the
present study has shown, the market shares
for profitable operating in the European mar-
ket are not overwhelming. If one accepts a dis-
counted payback period of 22 years and net
cash flow percentage of 5%, the required mar-
ket share is 0.36%. Therefore, in order to beco-
me profitable in the European market, the
minimum targeted market share should be
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approximately 0.4% which is consistent with
a net sales target of 6 million euros for the
first year. Under more favourable conditions,
NPV can be much greater than zero and the
discounted payback period less than 10 years.
A market share of 0.4% can be seen as an
achievable one especially as some over 300
AIs are currently included in the review pro-
gramme of the BPD. Hypothetically, if all 300
AIs would have an equal market share it would
equal 0.33%. The market share limit calcula-
ted in the present study is somewhat higher
but still in the same range. Thus for an effi-
cient, new product, a market share of 0.4%
appears realistic. In addition, the demand for
new, efficient biocides can be argued to increa-
se as the number of currently used AIs decrea-
ses due to implementation of the BPD which
reduces the amount of alternative AIs.
In addition to chemical preservatives, there
is also interest in alternative preservation
methods. However, it seems highly unlikely
or even impossible that these would rule out
the chemical methods entirely. Rather, the
development of non-chemical methods is
extremely important, but in many cases these
methods can be utilized alongside or in addi-
tion to chemicals. As an example, the develop-
ment of preserving package technologies is a
fertile field, whereas increasing the amount
of disposable packages vs. chemicals should
be carefully evaluated. Disposable packages
increase the amount of waste and therefore
are not necessarily the only sustainable alter-
Market share % Market share %
0.3 0.4
Cash flow % Cash flow %
5 10 20 5 10 20
Year Time period Discount factor NPV of cash flows (M€) NPV of cash flows (M€)
2009* 0 0 -3.13 -3.13 -3.13 -3.13 -3.13 -3.13
2009 1 0.909 -2.93 -2.72 -2.31 -2.86 -2.58 -2.04
2010 2 0.826 -2.73 -2.33 -1.52 -2.59 -2.06 -0.99
2011 3 0.751 -2.54 -1.95 -0.77 -2.34 -1.56 0.02
2012 4 0.683 -2.36 -1.59 -0.04 -2.1 -1.07 0.99
2013 5 0.621 -2.18 -1.24 0.65 -1.87 -0.61 1.92
2014 6 0.564 -2.02 -0.9 1.32 -1.65 -0.16 2.81
2015 7 0.513 -1.86 -0.59 1.95 -1.44 0.26 3.64
2016 8 0.467 -1.71 -0.3 2.53 -1.24 0.65 4.42
2017 9 0.424 -1.58 -0.02 3.08 -1.06 1.01 5.15
2018 10 0.386 -1.45 0.23** 3.60 -0.89 1.35 5.84
2019 11 0.350 -1.33 0.47 4.08 -0.73 1.68 6.48
2020 12 0.319 -1.22 0.7 4.53 -0.58 1.98 7.08
2021 13 0.290 -1.11 0.91 4.94 -0.44 2.25 7.63
2022 14 0.263 -1.02 1.1 5.32 -0.31 2.50 8.14
2023 15 0.239 -0.93 1.27 5.67 -0.2 2.74 8.60
2024 16 0.218 -0.85 1.43 5.99 -0.09 2.95 9.03
2025 17 0.198 -0.78 1.58 6.29 0.01 3.15 9.42
2026 18 0.180 -0.71 1.71 6.56 0.10 3.33 9.78
2027 19 0.164 -0.65 1.84 6.80 0.18 3.49 10.1
2028 20 0.149 -0.59 1.95 7.03 0.26 3.64 10.4
2029 21 0.135 -0.54 2.05 7.24 0.33 3.78 10.7
2030 22 0.123 -0.49 2.15 7.43 0.39 3.91 11.0
Table 5 Estimated net present values using a discount rate of 10%
Feasibility of Active Ingredient (AI) Development for New Biocides in the EU
* This row represents time at the beginning of the year 2009 and the cash flows in the row represent the start-up costs.
** The year of the discounted payback period, DPP, (i.e. the value of the NPV is positive) is indicated by highlighting the cell
with dark gray.
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native for chemicals.
As the BPD requires registration of both
new and old biocides (Bruns et al., 2005) also
existing AIs in the market will require invest-
ments. Consequently, this would argue on
behalf of the importance of new AI develop-
ment as costs of registration are inevitable if
the aim is to stay in the biocide market. In
addition, as the biocide market may become
more stagnated, a new AI may rapidly gain
visibility and the producer of a new AI may
become recognized as a technology leader. On
the other hand, if new AIs are not developed,
then it may be wise for companies to include
a broader range of control of biodegradation,
including also non-chemical means of control.
Controversially, however, the increasing
demand for non-chemical, ecologically more
acceptable means for control may become a
barrier to entrance of new AIs. On the other
hand, it is unlikely, that non-chemical alter-
natives solely would be adequate for all pur-
poses in the near future, whereas a new AI
together with non-chemical means could per-
haps offer a highly versatile product portfolio
for a biocide producer.
Although one of the goals of the emerging
regulatory framework for chemicals within
the EU strives to boost innovation within the
Community, it is evident that the implemen-
tation of regulatory initiatives may also pose
a possible barrier for new AI development. Evi-
dently, the competitiveness of the EU market
is inherently tied also to international trade
and harmonisation of regulatory initiatives
worldwide. If harmonisation of legislation does
not support the competitiveness of the EU as
intended by the Community regulatory fra-
mework, unexpected challenges for AI deve-
lopment might occur, as global requirements
will differ and increase the cost of a “univer-
sally” acceptable new AI.
New AI development should be based on a
standardized and reliable protocol for biocide
efficacy testing. However, at the moment effi-
cacy testing methods for biocides vary accor-
ding to the industry application and can also
be seen as a barrier for new products entering
the market. The pharmaceuticals industry is
an example of an industry which has a clear-
ly defined testing protocol for efficacy testing
and acceptance criteria (Meyer et al., 2007). In
many other industries various different effi-
cacy testing methods and protocols exist (Gil-
latt, 1991; Heinken, 2000). Therefore, biocide
efficacy testing is clearly an area that needs
to be further studied and developed in order
for the efficacy of new AIs to be verifiable.
In conclusion, development of new AIs is
technologically and economically feasible. Cle-
arly also non-chemical alternatives for preser-
vation should be considered, possibly in con-
junction with chemical biocides development.
Alternative means of microbial control are
often less toxic to the user, consumer and the
environment, but limited as to the range of
applications where such methods can be used.
On the other hand, chemical biocides clearly
suffer from toxicity, which, however, is inhe-
rent to their activity and required efficacy pro-
file. Consequently, the challenge for biocides
and control of biodeterioration in the future
is ingrained into formulating the “non-toxic
poison” for which the price-tag remains to be
determined.
Kaisa Soirinsuo, Elina Kähkönen, Jouko Karjalainen and Katrina Nordström
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INDUSTRY
Adhesives and related products,
cosmetics and skin care products,
polymer dispersions
Pharmaceuticals
Biocides (for the use of mainly pulp and
paper industry)
THEME 1.   MICROBIOLOGICAL RISKS
• what microbes, what kind of problems • what microbes, what kind of problems • most important industries as
clients what microbes, what kind of
problems (that clients have)
• preservability of products • how much preservatives are used • most important AIs in manufactured
biocides
• quality control, detection of spoilage • the meaning of use-by date in pharma-
ceuticals
• prevention of spoilage or prevention of
pathogens
• biocides in use currently (in products /
processes)
• quality control, detection of spoilage • alterations in biocide formulae due to
microbial resistance
• resistance towards biocides • biocides in use currently (in products /
processes)
• allowed concentrations of preservati-
ves
• resistance towards biocides
THEME 2.   REGULATION AND RISKS OF CHEMICALS
• eco-labels, warning labels or environ-
mental strategies affecting biocide use
• changes in use of biocides • eco-labels, warning labels or environ-
mental strategies affecting biocides
• changes in use of biocides • regulations or directives affecting the
use of preservatives
• changes in formulas of biocidal pro-
ducts
• effects of the BPD * • requirements of preservatives in sales
permit applications
• effects of the BPD
• needs from (new) biocides • differences between EU and USA with
reference to preservatives
• clients’ needs from (new) biocides
• interests in cooperation with biocide
development 
• needs from (new) biocides • importance of development of new AIs,
interests in cooperation with AI deve-
lopment
• interests in cooperation with biocide
development
• non-biocidal alternatives and their rele-
vance
THEME 3.   CONSUMERS
• complaints due to microbial spoilage • complaints due to microbial spoilage • could some new chemical operate as
sales promotion (for your clients’ pro-
ducts)
• could some new chemical operate as
sales promotion (for products)
• preservatives with reference to allergy
tests
• sensitivity (human) to preservatives **
* not asked from the representative of the cosmetics field
** asked only from the representative of the cosmetics field
Table 1 Themes and topics of industry interviews
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Appendix 2
QUESTION THEMES Specific questions
Preservative allergies
• number of allergies and source of information of allergies
• preservatives causing most allergies and possible recommendations for compa-
nies of which preservatives to use
• product types mostly related to allergies
• allergy tests and evaluation methods
• consumer awareness of preservatives
• correlation between microbes and allergies
”Allergy safe”
• are there international standards for allergy labels
• number of applications for the “allergy safe” label and types of products applied
for
• effect of  “allergy safe” label on consumer purchase decisions
• new product groups having the allergy label 
• recommendations for companies on preservatives
Table 2 Allergy and Asthma Federation (Finland) interview
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